Reem Hal/LinkedIn
Dec 25, 2025, 23:39
Reem Hal Shares New Clinical Capsule: Thrombosis in Cancer Patients
Reem Hal, Senior Pediatric Oncology Clinical Pharmacist at Borg El Arab Main University Hospital, shared a post on LinkedIn:
“Clinical Capsule | Oncology Rounds
Capsule #5 – Thrombosis in Cancer Patients
‘The cancer didn’t cause the ICU admission — the missed prophylaxis did.’
A patient with multiple myeloma on
lenalidomide + dexamethasone
missed thromboprophylaxis →
acute myocardial infarction. ICU admission.
Clinical Pearl
IMiD-based regimens dramatically increase thrombotic risk.
Standard practice
- Low risk → Aspirin
- High risk → LMWH or DOAC
Missed prophylaxis may lead to
- MI or stroke
- Treatment interruption
Take-home message
In multiple myeloma, thromboprophylaxis is not optional — it is life-saving.”
Follow the latest in Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?